Matheson N, Bathurst I, Travis J
Dept. of Biochemistry, University of Georgia, Athens 30602.
Biochem Biophys Res Commun. 1989 Feb 28;159(1):271-7. doi: 10.1016/0006-291x(89)92433-9.
The replacement of ser359 with ala359 at the P1 position in human alpha-1-proteinase inhibitor results in the production of a variant protein containing 15% of the inhibitory activity of the normal inhibitor. Separation of active from inactive inhibitor on anhydrochymotrypsin-sepharose yields a form which has a second order association rate with neutrophil elastase which is approximately one half that for the native protein. These data indicate that the P1 residue is not of primary importance during the interaction of proteinases with alpha-1-proteinase inhibitor. Since substitution of alanine for serine causes the formation, primarily, of inactive inhibitor the major function of ser359 probably involves proper folding to give a functionally active inhibitory conformation.
在人α-1-抗胰蛋白酶的P1位置将丝氨酸359替换为丙氨酸359,会产生一种变体蛋白,其抑制活性仅为正常抑制剂的15%。在脱水胰凝乳蛋白酶-琼脂糖上分离活性抑制剂和非活性抑制剂,得到的一种形式与中性粒细胞弹性蛋白酶的二级缔合速率约为天然蛋白的一半。这些数据表明,在蛋白酶与α-1-抗胰蛋白酶相互作用过程中,P1残基并非至关重要。由于用丙氨酸取代丝氨酸主要导致非活性抑制剂的形成,丝氨酸359的主要功能可能涉及正确折叠以形成功能活性抑制构象。